Mr. Chair, I rise in opposition to H.R. 4368, which has been weaponized to further limit Americans' access to reproductive healthcare. Hidden in this bill is an attempt to reinstate medically unnecessary and outdated FDA policies that…
Mr. Chair, I rise in opposition to H.R. 4368, which has been weaponized to further limit Americans' access to reproductive healthcare. Hidden in this bill is an attempt to reinstate medically unnecessary and outdated FDA policies that restrict access to mifepristone, a safe, effective drug used in medication abortion and miscarriage management care.
From the courts to Congress, my colleagues in the majority are continuing their efforts to force burdensome restrictions that attack our fundamental freedoms to make our own decisions about our own bodies.
This funding bill is yet another example of political interference into the scientific review process entrusted to the FDA by Congress. It is a draconian attempt to strip away people's fundamental freedom to make their own decisions, make their own medical decisions, rejecting years of scientific and medical expertise and an extensive evidence- based review that showed mifepristone to be incredibly safe.
Mifepristone is safe and effective, and it is not the business of Congress to substitute political judgments for the judgments of the scientific and medical experts who determine FDA policy governing this medication.
What is even more unfortunate is that this is just one of many problematic aspects of this bill. As a member of the House Committee on Agriculture, I could spend hours walking my colleagues through how cutting funding to 2003 levels leaves our farmers and working families behind.
I know my colleagues on the other side of the aisle who sit on the Agriculture Committee with me do not view this to be a serious proposal. I challenge them to think long and hard about how they will communicate this to farmers back home before voting ``yes'' on this bill.
For these reasons, at the appropriate time, I will offer a motion to recommit this bill back to committee.
If the House rules permitted, I would have offered the motion with an important amendment to this bill. My amendment would strike the provisions rolling back FDA's guidance.
Mr. Chair, I include in the Record the text of my amendment, and I hope my colleagues will join me in voting for the motion to recommit.
Ms. Budzinski moves to recommit the bill H.R. 4368 to the
Committee on Appropriations with the following amendment:
Page 109, beginning on line 1, strike section 761.